MovDisordV3, Main, Merge, bibRecord, 005526

Re: Cabergoline versus levodopa monotherapy: A decision analysis

Identifieur interne : 005526 ( Main/Merge ); précédent : 005525; suivant : 005527

Re: Cabergoline versus levodopa monotherapy: A decision analysis

Auteurs : Connie Marras [Canada]

Source :

Movement Disorders [ 0885-3185 ] ; 2004-06.

RBID : ISTEX:C64B223EC1E609CA4F0CCE8001B59E268FEB5076

English descriptors

KwdEn :
- Age Factors, Antiparkinson Agents (economics), Antiparkinson Agents (therapeutic use), Cost-Benefit Analysis, Decision Support Techniques, Ergolines (economics), Ergolines (therapeutic use), Humans, Levodopa (economics), Levodopa (therapeutic use), Middle Aged, Parkinson Disease (drug therapy), Parkinson Disease (economics), Prospective Studies, Questionnaires.
MESH :
- chemical , economics : Antiparkinson Agents, Ergolines, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Ergolines, Levodopa.
- drug therapy : Parkinson Disease.
- economics : Parkinson Disease.
- Age Factors, Cost-Benefit Analysis, Decision Support Techniques, Humans, Middle Aged, Prospective Studies, Questionnaires.

Url:

https://api.istex.fr/document/C64B223EC1E609CA4F0CCE8001B59E268FEB5076/fulltext/pdf

DOI: 10.1002/mds.20031

Links to Exploration step

ISTEX:C64B223EC1E609CA4F0CCE8001B59E268FEB5076

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Re: Cabergoline versus levodopa monotherapy: A decision analysis</title>
<author><name sortKey="Marras, Connie" sort="Marras, Connie" uniqKey="Marras C" first="Connie" last="Marras">Connie Marras</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C64B223EC1E609CA4F0CCE8001B59E268FEB5076</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20031</idno>
<idno type="url">https://api.istex.fr/document/C64B223EC1E609CA4F0CCE8001B59E268FEB5076/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003417</idno>
<idno type="wicri:Area/Istex/Curation">003417</idno>
<idno type="wicri:Area/Istex/Checkpoint">002549</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Marras C:re:cabergoline:versus</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15197726</idno>
<idno type="wicri:Area/PubMed/Corpus">003422</idno>
<idno type="wicri:Area/PubMed/Curation">003422</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003338</idno>
<idno type="wicri:Area/Ncbi/Merge">000E62</idno>
<idno type="wicri:Area/Ncbi/Curation">000E62</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E62</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Marras C:re:cabergoline:versus</idno>
<idno type="wicri:Area/Main/Merge">005526</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Re: Cabergoline versus levodopa monotherapy: A decision analysis</title>
<author><name sortKey="Marras, Connie" sort="Marras, Connie" uniqKey="Marras C" first="Connie" last="Marras">Connie Marras</name>
<affiliation wicri:level="1"><country wicri:rule="url">Canada</country>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Movement Disorders Centre, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-06">2004-06</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="736">736</biblScope>
<biblScope unit="page" to="736">736</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C64B223EC1E609CA4F0CCE8001B59E268FEB5076</idno>
<idno type="DOI">10.1002/mds.20031</idno>
<idno type="ArticleID">MDS20031</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age Factors</term>
<term>Antiparkinson Agents (economics)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Cost-Benefit Analysis</term>
<term>Decision Support Techniques</term>
<term>Ergolines (economics)</term>
<term>Ergolines (therapeutic use)</term>
<term>Humans</term>
<term>Levodopa (economics)</term>
<term>Levodopa (therapeutic use)</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (economics)</term>
<term>Prospective Studies</term>
<term>Questionnaires</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Ergolines</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Ergolines</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Age Factors</term>
<term>Cost-Benefit Analysis</term>
<term>Decision Support Techniques</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Questionnaires</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<double doi="10.1002/mds.20031"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Re: Cabergoline versus levodopa monotherapy: A decision analysis</title>
<author><name sortKey="Marras, Connie" sort="Marras, Connie" uniqKey="Marras C" first="Connie" last="Marras">Connie Marras</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C64B223EC1E609CA4F0CCE8001B59E268FEB5076</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20031</idno>
<idno type="url">https://api.istex.fr/document/C64B223EC1E609CA4F0CCE8001B59E268FEB5076/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003417</idno>
<idno type="wicri:Area/Istex/Curation">003417</idno>
<idno type="wicri:Area/Istex/Checkpoint">002549</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Marras C:re:cabergoline:versus</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Re: Cabergoline versus levodopa monotherapy: A decision analysis</title>
<author><name sortKey="Marras, Connie" sort="Marras, Connie" uniqKey="Marras C" first="Connie" last="Marras">Connie Marras</name>
<affiliation wicri:level="1"><country wicri:rule="url">Canada</country>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Movement Disorders Centre, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-06">2004-06</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="736">736</biblScope>
<biblScope unit="page" to="736">736</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C64B223EC1E609CA4F0CCE8001B59E268FEB5076</idno>
<idno type="DOI">10.1002/mds.20031</idno>
<idno type="ArticleID">MDS20031</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Re: Cabergoline versus levodopa monotherapy: a decision analysis.</title>
<author><name sortKey="Marras, Connie" sort="Marras, Connie" uniqKey="Marras C" first="Connie" last="Marras">Connie Marras</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15197726</idno>
<idno type="pmid">15197726</idno>
<idno type="doi">10.1002/mds.20031</idno>
<idno type="wicri:Area/PubMed/Corpus">003422</idno>
<idno type="wicri:Area/PubMed/Curation">003422</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003338</idno>
<idno type="wicri:Area/Ncbi/Merge">000E62</idno>
<idno type="wicri:Area/Ncbi/Curation">000E62</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E62</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Marras C:re:cabergoline:versus</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Re: Cabergoline versus levodopa monotherapy: a decision analysis.</title>
<author><name sortKey="Marras, Connie" sort="Marras, Connie" uniqKey="Marras C" first="Connie" last="Marras">Connie Marras</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age Factors</term>
<term>Antiparkinson Agents (economics)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Cost-Benefit Analysis</term>
<term>Decision Support Techniques</term>
<term>Ergolines (economics)</term>
<term>Ergolines (therapeutic use)</term>
<term>Humans</term>
<term>Levodopa (economics)</term>
<term>Levodopa (therapeutic use)</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (economics)</term>
<term>Prospective Studies</term>
<term>Questionnaires</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Ergolines</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Ergolines</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Age Factors</term>
<term>Cost-Benefit Analysis</term>
<term>Decision Support Techniques</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Questionnaires</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
</PubMed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005526 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 005526 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:C64B223EC1E609CA4F0CCE8001B59E268FEB5076
   |texte=   Re: Cabergoline versus levodopa monotherapy: A decision analysis
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Re: Cabergoline versus levodopa monotherapy: A decision analysis

Re: Cabergoline versus levodopa monotherapy: A decision analysis

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.